Overview Excretion of Rivaroxaban in Human Breast Milk Status: RECRUITING Trial end date: 2026-07-31 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.Phase: PHASE1 Details Lead Sponsor: Thomas Jefferson UniversityTreatments: RivaroxabanTablets